Inhibition of platelet GPIIbIIa in an ex vivo model of hyperacute xenograft rejection does not prolong cardiac survival time

Xenotransplantation

Volumn 3, Issue 1 PART 1, 1996, Pages 43-52

  Robson, Simon C ^a   Young, Vincent K ^b,d   Cook, Nigel S ^b,d   Kottirsch, Georg ^c   Siegel, Jonathan B ^a   Lesnikoski, Beth Ann ^a   Candinas, Daniel ^a   White, David J G ^b,d   Bach, Fritz H ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Preclinical Research   (Switzerland)

^d Imutran Limited   (United Kingdom)

Author keywords

GPIb; GPIIbIIIa; Platelet; Swine

Indexed keywords

EID: 0030061977     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1996.tb00117.x     Document Type: Article

References (39)

1. BACH FH, ROBSON SC, FERRAN C, WINKLER H, MILLAN MT, STUHLMEIER K, VANHOVE B, et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994:141:5.
2. AUCHINCLOSS H JR. Xenografting: a review. Transplantation 1990:4:14.
3. BALDWIN III WM, PRUITT SK, BRAUER RB, DAHA RM, SANFILIPPO F. Complement in organ transplantation. Transplantation 1995:59:797.
4. DALMASSO AP, VERCELLOTTI GM, FISCHEL RJ, BOLMAN RM, BACH FH, PLATT JL. Mechanisms of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992:140:1157.
5. PLATT JL, BACH FH. Discordant xenografting: challenges and controversies. Curr Opin Immunol 1991:3:735.
6. ROBSON SC, KOPP C, LESNIKOSKI B. Platelets and xenograft rejection. Xenotransplantation 1994:2:38.
7. BLAKELY ML, VAN DER WERF WJ, BERNDT MC, DALMASSO AP, BACH FH, HANCOCK WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994:58:1059.
8. ROBSON SC, CANDINAS D, HANCOCK WW, WRIGHTON C, WINKLER H, BACH FH. The role of endothelial cells in transplantation. Int Arch Allergy Immunol 1995:106:305.
9. ESMON CT. Cell mediated events that control blood coagulation and vascular injury. Annu Rev Cell Biol 1993:9:1.
10. MAKOWKA L, CHAPMAN FA, CRAMER DV, QIAN S, SUN H, STARZL TE. Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitised hosts. Transplantation 1990:50:359.
11. MANN KG. Prothrombin and thrombin. In: Coleman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: JP Lippincott, 1994.
12. HUNT BJ, ROSENBERG RD. The essential role of haemostasis in hyperacute rejection. Xenotransplantation 1993:1:16.
13. PARETI FI, MAZZUCATO M, BOTTINI E, MANNUCCI PM. Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex. Br J Haematol 1992:82:81.
14. COUGHLAN AF, BERNDT MC, DUNLOP LC, HANCOCK WW. In vivo studies of P-selectin and platelet-activating factor during endotoxemia, accelerated allograft rejection and discordant xenograft rejection. Transplant Proc 1993: 25:2930.
15. COOK NS, KOTTIRSCH G, ZERWES HG. Platelet glycoprotein IIb/IIIa antagonists. Drugs Future 1994:19:135.
16. FORTY J, WHITE DG, WALLWORK J. A technique for perfusion of an isolated working heart to investigate hyperacute discordant xenograft rejection. J Thorac Cardiovasc Surg 1993:106:308.
17. SUCKFULL MM, PIESKE O, MUDSAM M, BASIC R, HAMMER C. The contribution of endothelial cells to hyperacute rejection in xenogeneic perfused working hearts. Transplantation 1994:57:262.
18. GAUTREAU C, CARDOSO J, JEYARAJ P, ET AL. Relationship between human anti-A, anti-B alloantibodies and anti-pig xenoantibodies. Transplant Proc 1993:25:389.
19. HOLMSEN H. Platelet secretion and energy metabolism. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: JP Lippincott, 1994.
20. COLMAN RW, COOK JJ, NIEWIAROWSKI S. Mechanisms of platelet activation. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: JP Lippincott, 1994.
21. SIMS PJ, WIEDMER T. The response of human platelets to activated components of the complement system. Immunol Today 1991:12:338.
22. DALMASSO AP. The complement system in xenotransplantation. Immunopharmacology 1992:24:149.
23. PLATT JL, FISCHEL RJ, MATAS AJ, REIF SA, BOLMAN RM, BACH FH. Immunopathology of hyperacute rejection in a swine to primate model. Transplantation 1991:52:214.
24. SALZMAN EW, ROSENBERG RD, SMITH MH, LINDON JN, FAVREAU L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980:65:64.
25. ROSE AG, COOPER DKC, HUMAN PA, REICHENSPURNER H, REICHART B. Histopathology of hyperacute rejection of the heart: Experimental and clinical observations in allografts and xenografts. J Heart Lung Transplantation 1991:10:223.
26. COOPER DKC, YE Y, ROLF JLL, ZUHDI N. The pig as potential organ donor for man. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xeno-transplantation. The Transplantation of Organs and Tissues Between Species. Berlin: Springer-Verlag, 1991.
27. CALNE RY. Organ transplantation between widely disparate species. Transpl Proc 1970:2:550.
28. MOAT NE, SHORE DF, EVANS TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993:7:563.
29. PEERSCHKE EIB, REID KBM, GHEBREHIWET B. Platelet activation by C1q results in the induction of GP IIbIIIa and the expression of P-selectin and procoagulant activity. J Exp Med 1993:178:579.
30. CARSON SD, JOHNSON DR. Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. Blood 1990:76:361.
31. SIMS PJ, WIEDMER T. Repolarisation of the membrane potential of blood platelets after complement damage: evidence for calcium dependent exocytotic elimination of C5b-9 pores. Blood 1986:68:556.
32. ALBELDA SM, SMITH CW, WARD PA. Adhesion molecules and inflammatory injury. FASEB J 1994:8:504.
33. COOK NS, BRUTTGER O, PALLY C, HAGENBACH A. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active. Thromb Haemost 1993:70:838.
34. ROBSON SC, SIEGEL JB, LESNIKOSKI BA, KOPP C, CANDINAS D, RYAN U, BACH FH. Aggregation of human platelets induced by porcine endothelial cells is dependent upon both activation of complement and thrombin generation. Xenotransplantation 1996:3:24-34.
35. ZEHR KJ, HERSKOWITZ A, LEE PC, KUMAR P, GILLINOV AM, BAUMGARTNER WA. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 1994:57:900.
36. ROSENGARD AM, CARY NRB, LANGFORD GA, TUCKER AW, WALLWORK J, WHITE DJG. Tissue expression of human complement inhibitor, decay accelerating factor (DAF), in transgenic pigs - a potential approach for preventing xenograft rejection. Transplantation 1995 (in press).
37. MCCURRY KR, KOOYMAN DL, ALVARADO CG, COTTERELL AH, MARTIN MJ, LOGAN JS, PLATT JL. Human complement regulatory proteins protect swine to primate cardiac xenografts from humoral injury. Nature Med 1995:1:423.
38. PRUITT SK, KIRK DA, BOLLINGER RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994:57:363.
39. MARCUS AJ, SAFIER LB. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 1993:7:516.